Rigosertib Sodium
| CAS No. | 592542-60-4 |
|---|---|
| MDL No. | MFCD11655911 |
| MF | C21H24NNaO8S |
| MW | 473.50 |
| InChI Key | VLQLUZFVFXYXQE-USRGLUTNSA-M |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Rigosertib sodium is the sodium salt of rigosertib. It is an anti-cancer agent with Orphan Drug Designation by the FDA for myelodysplastic syndromes (MDS). It functions as a microtubule-destabilizing agent, antineoplastic agent, polo kinase (EC 2.7.11.21) inhibitor, and apoptosis inducer. It contains a rigosertib(1-).
| CAS No. | 592542-60-4 |
|---|---|
| Product Name | Rigosertib Sodium |
Associated Conditions
chronic myelogenous leukemia·myelodysplastic syndrome·ovarian cancer·neoplasm·chronic myelomonocytic leukemia·
* The information provided here is compiled from public sources and is for reference only.
